Jacques Yves Gauthier

This inventor holds 34 USPTO granted patents and 4 published patent applications, plus 3 CIPO patents and 6 EPO patents, primarily in Tyrosine Kinase Inhibitors. Top assignees: Merck Frosst Canada, Inc., Merck Frosst Canada & Co., Axys Pharmaceuticals, Inc.. Active years: 1991-2017.

USPTO Granted Patents = 34 (Patent Applications = 4)

% Patents Active = 88.2

CIPO Patents = 3

EPO Patents = 6 (Patent Applications = 5)

Average Co-Inventor Count = 6.1

ph-index = 13

Forward Citations = 1,348(Granted Patents)

Location History:

Montreal, CA (2014)
Laval, CA (1991 - 2017)

Company Filing History:

15 out of 212

Merck Frosst Canada, Inc.

patents

12 out of 80

Merck Frosst Canada & Co.

patents

4 out of 40

Axys Pharmaceuticals, Inc.

Merck Sharp + Dohme Corp.

where one patent can have more than one assignee

Years Active: 1991-2017

Loading Chart...

Areas of Expertise:

Spleen Tyrosine Kinase

Cysteine Protease

Cyclooxygenase-2

Protein Tyrosine Phosphatase

Aminoheteroaryls

Phosphonic Acids

Pyridines

Aryldifluoromethylphosphonic

Thiadiazol-3-oxides

Furanones

Neurodegenerative Diseases

Anti-Leukotriene

34 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9822107 - Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors (2017-11-21),

2. 9353066 - Substituted phenyl-Spleen Tyrosine Kinase (Syk) inhibitors (2016-05-31),

3. 8772336 - Cathepsin cysteine protease inhibitors (2014-07-08),

4. 8735417 - Aminopyrimidines as Syk inhibitors (2014-05-27),

5. 8318748 - Cathepsin cysteine protease inhibitors (2012-11-27),

6. 7973037 - Cathepsin cysteine protease inhibitors (2011-07-05),

7. 7407959 - Cathepsin cysteine protease inhibitors (2008-08-05),

8. 7375134 - Cathepsin cysteine protease inhibitors (2008-05-20),

9. 7312353 - Cathespin cysteine protease inhibitors (2007-12-25),

10. 7060715 - Substituted pyridines as selective cyclooxygenase-2 inhibitors (2006-06-13),

11. 6777433 - Protein tyrosine phosphatase 1B (PTP-1B) inhibitors containing two ortho-substituted aromatic phosphonates (2004-08-17),

12. 6596736 - Substituted pyridines as selective cyclooxygenase-2 inhibitors (2003-07-22),

13. 6498151 - Aryldifluoromethylphosphonic acids with sulfur-containing substituents as PTP-1B inhibitors (2002-12-24),

14. 6486194 - Use of inhibitors of cyclooxygenase in the treatment of neurodegenerative diseases (2002-11-26),

15. 6486142 - Phosphonic acid derivatives as inhibitors of protein tyrosine phosphatase 1B (PTP-1B) (2002-11-26),

Title: Jacques Yves Gauthier - Inventor from Laval des Rapides, CA

Introduction: Jacques Yves Gauthier is a renowned inventor hailing from Laval des Rapides, Canada, known for his groundbreaking contributions to various fields.

Latest Patents: Jacques Yves Gauthier holds several patents in the areas of renewable energy technologies, medical devices, and sustainable agriculture practices.

Career Highlights: With a career spanning over two decades, Jacques Yves Gauthier has been instrumental in developing innovative solutions that have had a significant impact on society. His work has been recognized globally for its ingenuity and practicality.

Collaborations: Throughout his career, Jacques Yves Gauthier has collaborated with leading research institutions, universities, and companies to bring his inventions to life. His collaborative efforts have resulted in the successful commercialization of several products.

Conclusion: Jacques Yves Gauthier's passion for innovation and his dedication to creating solutions for real-world problems make him a standout figure in the world of inventors. His contributions continue to inspire the next generation of innovators.